Ambirix ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
107Juvenile idiopathic arthritis1

107. Juvenile idiopathic arthritis


Clinical trials : 441 Drugs : 282 - (DrugBank : 56) / Drug target genes : 52 - Drug target pathways : 142
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2008-003280-40-NL
(EUCTR)
30/06/200923/02/2009Response to hepatitis A and B vaccine among children with immunesuppression due to either hiv or immunesuppressive medication - Ambirixresponse immunesuppressed childrenResponse to hepatitis A and B vaccine among children with immunesuppression due to either hiv or immunesuppressive medication - Ambirixresponse immunesuppressed children The effectiveness of Ambirix will be investigated in 2 groups:1) children with hiv-infection, with CD4 counts > 15%2) children with a rheumatic disease for which immune-suppressive medication is used.
MedDRA version: 9.1;Level: LLT;Classification code 10002725;Term: Anti-HIV positive
MedDRA version: 9.1;Classification code 10059176;Term: Juvenile idiopathic arthritis
Trade Name: Ambirix
Trade Name: Ambirix
Public Health Service AmsterdamNULLNot RecruitingFemale: yes
Male: yes
Netherlands